Nuclide Therapeutics Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2024Private Limited Company
Financial position
Accounts to 2026-03-31 · GBP · Company accounts
Net assets
£1,940,744
Cash
£1,933,182
Turnover
—
Profit / loss
—
Current assets
£1,942,220
Creditors < 1 year
—
Equity
—
Average employees
3
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-03-31Company | 2025-03-31Company |
|---|---|---|
| Balance sheet | ||
| Net assets | £1,940,744 | −£173 |
| Assets | ||
| Fixed assets | £6,564 | £0 |
| Property, plant & equipment | £6,564 | £0 |
| Current assets | £1,942,220 | £26 |
| Cash at bank | £1,933,182 | £26 |
| Debtors | £9,038 | £0 |
| Liabilities | ||
| Creditors | £8,040 | £199 |
| Net current assets | £1,934,180 | −£173 |
| Assets less current liabilities | £1,940,744 | −£173 |
| People & pay | ||
| Average employees | 3 | 0 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFixed · created 2025-10-17
—
Outstanding